69.95
price down icon1.14%   -0.81
after-market アフターアワーズ: 69.85 -0.10 -0.14%
loading
前日終値:
$70.76
開ける:
$71.14
24時間の取引高:
6.29M
Relative Volume:
1.24
時価総額:
$228.90B
収益:
$54.98B
当期純損益:
$7.77B
株価収益率:
28.09
EPS:
2.49
ネットキャッシュフロー:
$9.14B
1週間 パフォーマンス:
-6.01%
1か月 パフォーマンス:
+0.04%
6か月 パフォーマンス:
+7.04%
1年 パフォーマンス:
-10.96%
1日の値動き範囲:
Value
$69.66
$71.14
1週間の範囲:
Value
$69.66
$74.75
52週間の値動き範囲:
Value
$61.24
$87.67

Astrazeneca PLC Stock (AZN) Company Profile

Name
名前
Astrazeneca PLC
Name
セクター
Healthcare (1174)
Name
電話
44 20 3749 5000
Name
住所
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge
Name
職員
61,100
Name
Twitter
@AstraZeneca
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
AZN's Discussions on Twitter

AZN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Major icon
AZN
Astrazeneca PLC
69.95 228.90B 54.98B 7.77B 9.14B 2.49

Astrazeneca PLC Stock (AZN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-15 開始されました Exane BNP Paribas Outperform
2025-02-13 アップグレード UBS Neutral → Buy
2025-02-12 開始されました Morgan Stanley Overweight
2024-11-20 アップグレード UBS Sell → Neutral
2024-11-06 アップグレード Deutsche Bank Sell → Hold
2024-09-13 ダウングレード Deutsche Bank Hold → Sell
2024-05-30 開始されました Goldman Buy
2024-04-16 アップグレード Deutsche Bank Sell → Hold
2024-02-08 ダウングレード Deutsche Bank Hold → Sell
2024-01-23 開始されました Morgan Stanley Overweight
2024-01-16 再開されました UBS Sell
2024-01-03 ダウングレード Jefferies Buy → Hold
2023-12-18 開始されました HSBC Securities Buy
2023-09-25 アップグレード Jefferies Hold → Buy
2023-07-14 開始されました HSBC Securities Buy
2023-07-12 アップグレード UBS Neutral → Buy
2023-07-05 ダウングレード Deutsche Bank Buy → Hold
2023-04-11 アップグレード Morgan Stanley Equal-Weight → Overweight
2023-01-05 開始されました BMO Capital Markets Outperform
2022-09-15 ダウングレード Credit Suisse Outperform → Neutral
2022-09-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-08-29 アップグレード Argus Hold → Buy
2022-06-14 ダウングレード UBS Buy → Neutral
2022-02-11 アップグレード DZ Bank Sell → Hold
2021-12-07 ダウングレード Jefferies Buy → Hold
2021-08-12 再開されました JP Morgan Overweight
2021-04-12 ダウングレード Argus Buy → Hold
2021-03-16 アップグレード Jefferies Hold → Buy
2021-02-25 アップグレード UBS Neutral → Buy
2021-01-15 開始されました Deutsche Bank Buy
2020-12-07 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-11-30 アップグレード UBS Sell → Neutral
2020-11-11 アップグレード HSBC Securities Reduce → Hold
2020-09-29 開始されました Berenberg Buy
2019-11-22 開始されました SVB Leerink Outperform
2019-10-25 アップグレード Liberum Hold → Buy
2019-04-02 ダウングレード UBS Neutral → Sell
2019-02-05 開始されました Exane BNP Paribas Outperform
2019-01-25 アップグレード Shore Capital Hold → Buy
2018-12-11 再開されました Jefferies Hold
2018-10-09 開始されました Guggenheim Buy
2018-08-16 ダウングレード Jefferies Buy → Hold
2018-03-19 アップグレード Jefferies Hold → Buy
2018-02-06 繰り返されました Leerink Partners Mkt Perform
2018-02-05 繰り返されました Bernstein Outperform
2018-01-18 繰り返されました Leerink Partners Mkt Perform
2017-12-29 アップグレード JP Morgan Neutral → Overweight
2017-10-16 アップグレード Credit Suisse Neutral → Outperform
2017-09-25 アップグレード Exane BNP Paribas Neutral → Outperform
2017-09-22 アップグレード Bernstein Mkt Perform → Outperform
すべてを表示

Astrazeneca PLC (AZN) 最新ニュース

pulisher
Jun 18, 2025

AstraZeneca (NASDAQ:AZN) PLC Stock Sees Institutional Growth on Nasdaq Composite - Kalkine Media

Jun 18, 2025
pulisher
Jun 18, 2025

AstraZeneca and GSK fall after Trump renews pharma tariff threat - Proactive Investors

Jun 18, 2025
pulisher
Jun 18, 2025

FTSE 100 Live: Stocks drop and oil spikes as Iran 'will not surrender', AstraZeneca falls on tariff threat - Proactive Investors

Jun 18, 2025
pulisher
Jun 18, 2025

FTSE 100 Live: Stocks drop into the red, AstraZeneca and GSK fall on Trump tariff threat - Proactive Investors

Jun 18, 2025
pulisher
Jun 18, 2025

AstraZeneca, GSK shares down after Trump threatens drug import tariffs By Investing.com - Investing.com Nigeria

Jun 18, 2025
pulisher
Jun 18, 2025

FTSE 100 Live: Stocks edge higher as UK inflation eases, AstraZeneca and GSK fall - Proactive Investors

Jun 18, 2025
pulisher
Jun 18, 2025

FTSE 100 Live: Stocks open higher as UK inflation eases, AstraZeneca and GSK fall - Proactive Investors

Jun 18, 2025
pulisher
Jun 17, 2025

Astrazeneca makes $5.3B drug R&D pact with CSPC - BioWorld MedTech

Jun 17, 2025
pulisher
Jun 17, 2025

AstraZeneca (AZN) Faces Potential Changes in Drug Advertising Ru - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Levi & Korsinsky Reminds AstraZeneca PLC Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025AZN - ACCESS Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

Jun 16, 2025
pulisher
Jun 15, 2025

AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer - Insider Monkey

Jun 15, 2025
pulisher
Jun 14, 2025

AstraZeneca | Pharmaceuticals, Vaccines, & Facts - Britannica

Jun 14, 2025
pulisher
Jun 13, 2025

Sector Update: Health Care Stocks Slide Late Afternoon - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca Inks Up To $5.3B AI Drug Deal With Chinese Firm - Law360

Jun 13, 2025
pulisher
Jun 13, 2025

FIVE AT FIVE: FTSE 100 unsettled by Israel strike; AstraZeneca strikes $3.6bn Chinese AI deal - Proactive financial news

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca and CSPC partner on AI drug research By Investing.com - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca and CSPC partner on AI drug research - Investing.com

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal - Pharmaceutical Technology

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca, CSPC Pharmaceuticals Enter Research Agreement - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca signs research agreement with China's CSPC (AZN) - Seeking Alpha

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans - BioPharma Dive

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca Taps Into China’s R&D Engine With CSPC Alliance - insights.citeline.com

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca Inks Research Pact With China's CSPC Pharmaceuticals Focused On AI-Driven Research, Valued Up To $5.33 BillionAstraZeneca (NASDAQ:AZN) - Benzinga

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca, Chinese bio firm sign $5.2B drug deal - breakingthenews.net

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca signs $5.2bn deal to develop drugs for chronic disease with Chinese biotech - Financial Times

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca Signs Nearly $5.3 Bln AI-enabled Research Deal With China's CSPC Pharma - Nasdaq

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca (AZN) Enters Collaboration with CSPC for Novel Thera - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca: R&D agreement with CSPC Pharmaceuticals Group - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca bets big on AI and China with $3.6bn CSPC collaboration - Proactive financial news

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca Enters Strategic Collaboration with CSPC Pharmaceuticals Group Limited - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca, CSPC Ink Strategic Research Collaboration for AI-Driven Drug Discovery - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

The Zacks Analyst Blog Highlights Microsoft, AstraZeneca and BlackRock, Taylor Devices and Geospace Technologies - TradingView

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca partners with CSPC in deal worth up to $5.33 billion - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca forms $5.3 billion AI drug discovery deal with CSPC - Investing.com

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca signs AI research deal with China's CSPC for chronic diseases - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca agrees to research deal worth up to $5.22 billion with CSPC - Yahoo Finance

Jun 13, 2025
pulisher
Jun 13, 2025

Astrazeneca Enters Collaboration Worth Up To $5.22 Bln With CSPC Pharmaceuticals - marketscreener.com

Jun 13, 2025
pulisher
Jun 12, 2025

Top Stock Reports for Microsoft, AstraZeneca & BlackRock - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Chancery Tags AstraZeneca Unit For $180M 'Expectation' Loss - Law360

Jun 12, 2025
pulisher
Jun 12, 2025

Leading bank sees AstraZeneca upside seen in hypertension drug, tempers lung cancer hopes - Proactive financial news

Jun 12, 2025
pulisher
Jun 12, 2025

AstraZeneca CFO Donates Shares to Charity - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

AstraZeneca CFO donates shares to charity - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

AstraZeneca CFO donates shares to charity By Investing.com - Investing.com UK

Jun 12, 2025
pulisher
Jun 12, 2025

REGAstraZeneca PLCDirector/PDMR Shareholding - TradingView

Jun 12, 2025
pulisher
Jun 12, 2025

AstraZeneca (AZN): Vaccine Advisory Panel Reshuffled, Impact on Pharma Stocks | AZN Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

UBS bullish on AstraZeneca’s baxdrostat, cautious on AVANZAR By Investing.com - Investing.com Nigeria

Jun 12, 2025
pulisher
Jun 12, 2025

At a bargain-basement valuation now, is AstraZeneca’s share price impossible for me to ignore? - Yahoo

Jun 12, 2025
pulisher
Jun 11, 2025

AstraZeneca (AZN) Watches CDC Vaccine Policy Developments | AZN Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

AstraZeneca Unit Owes $180 Million-Plus in Syntimmune Case (1) - Bloomberg Law News

Jun 11, 2025
pulisher
Jun 11, 2025

AstraZeneca, Lilly & J&J: Strategic Moves Powering SGLT‐2 - openPR.com

Jun 11, 2025

Astrazeneca PLC (AZN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
大文字化:     |  ボリューム (24 時間):